Dhopeshwarkar N, Yang W, Hennessy S, Rhodes JM, et al. Rate of major bleeding with ibrutinib versus bendamustine-rituximab in chronic lymphocytic leukemia: a population-based cohort study. Am J Hematol 2022 Jun 17. doi: 10.1002/ajh.26632.
PMID: 35713560